Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Doxycycline Hydrochloride prices in Germany, the highest-cost reporting region, corrected 5.1% in Q2 2026, slipping from USD 67.3/KG in Q1 to USD 63.9/KG as tetracycline synthesis intermediate cost softening and post-spring respiratory and antimalarial procurement moderation reversed the sustained Q3 2025 through Q1 2026 firming trend. Globally, the average eased from USD 46.33/KG in Q1 to USD 44.01/KG in Q2, a 5.0% decline. For H2 2026, a global average of USD 43.50-48.50/KG is expected, with stabilisation as synthesis costs normalise and steady respiratory infection, antimalarial prophylaxis, and acne management sector demand supports the market across all major regions.
Doxycycline Hydrochloride is a second-generation semi-synthetic tetracycline antibiotic produced by hydrogenolytic removal of the 6-hydroxyl group from oxytetracycline or by catalytic hydrogenation of methacycline over palladium catalysts, yielding the 6-deoxy-5-oxytetracycline active structure, converted to the stable monohydrochloride salt for pharmaceutical formulation. Compared to first-generation tetracyclines, doxycycline provides substantially improved oral bioavailability, a longer plasma half-life supporting once-daily dosing, and reduced renal clearance with biliary excretion making it suitable for patients with renal impairment. The compound exerts bacteriostatic activity by binding to the 30S ribosomal subunit and preventing aminoacyl-tRNA docking at the ribosomal acceptor site, blocking bacterial protein synthesis across a broad spectrum of Gram-positive, Gram-negative, atypical, and intracellular organisms. The largest pull comes from respiratory tract infection treatment including community-acquired pneumonia, Lyme disease management, and chlamydial infection treatment. Malaria prophylaxis for travellers to chloroquine-resistant regions, low-dose chronic acne management, anthrax post-exposure prophylaxis, and periodontitis treatment add further significant demand. Synthesis intermediate costs, respiratory infection treatment volumes, and regional API capacity all feed into the price.
The balance of supply and demand for Doxycycline Hydrochloride through H2 2026 leans toward stabilisation following the Q2 correction. Tetracycline synthesis intermediate costs are normalising after the Q1 2026 peak. Respiratory infection treatment, antimalarial prophylaxis, and acne management demand provide consistent procurement support.
The main upside risk is a renewed tetracycline synthesis cost spike alongside a respiratory illness surge or antimalarial prophylaxis programme expansion. The main downside risk is continued Chinese and Indian API surplus and generic competition maintaining price pressure below the forecast range.
| Region | Price Forecast (USD/KG) | Key Driver |
| Global Average | 43.50 - 48.50 | Synthesis cost normalisation and respiratory/antimalarial demand |
| United States | 46.60 - 51.60 | Steady respiratory and antimalarial prophylaxis demand holds firm |
| China | 32.30 - 37.30 | Domestic API capacity keeps it the most affordable |
| Germany | 64.40 - 69.40 | High synthesis and energy costs keep it the most expensive |
| India | 44.40 - 49.40 | Growing respiratory and export Rx demand holds a firm middle |
US Doxycycline Hydrochloride prices averaged USD 51.8/KG in Q2 2026, down 5.0% from USD 54.5/KG in Q1 2026. Tetracycline synthesis cost softening and post-spring respiratory and antimalarial procurement moderation eased the market from the Q1 firming peak.
Why did the price of Doxycycline Hydrochloride change in Q2 2026 in the United States?
Tetracycline synthesis intermediate cost softening reduced the API production floor. Post-spring respiratory, antimalarial, and Lyme disease treatment procurement moderation reduced buying urgency. Generic competition maintained price normalisation near USD 51.8/KG after the Q1 firming peak.
Chinese Doxycycline Hydrochloride prices averaged USD 35.7/KG in Q2 2026, down 5.1% from USD 37.6/KG in Q1 2026, the lowest among the tracked markets. Soft domestic synthesis costs and post-spring procurement moderation eased the market from the Q1 peak.
Why did the price of Doxycycline Hydrochloride change in Q2 2026 in China?
Soft domestic tetracycline synthesis intermediate costs reduced the production floor. Post-spring respiratory and antimalarial export and domestic procurement moderation reduced buying urgency. Domestic API capacity maintained China as the most affordable source.
German Doxycycline Hydrochloride prices averaged USD 63.9/KG in Q2 2026, down 5.1% from USD 67.3/KG in Q1 2026, the highest among the tracked markets. Softening tetracycline synthesis intermediate and energy costs and post-spring procurement moderation eased the European market from the Q1 firming peak.
Why did the price of Doxycycline Hydrochloride change in Q2 2026 in Germany?
Softening tetracycline synthesis intermediate and energy costs eased the European API production floor. Post-spring respiratory infection and antimalarial prophylaxis procurement moderation reduced buying urgency. The market corrected to USD 63.9/KG from the Q1 firming peak.
Indian Doxycycline Hydrochloride prices averaged USD 49.3/KG in Q2 2026, down 5.0% from USD 51.9/KG in Q1 2026. Soft synthesis import costs and post-spring respiratory and antimalarial procurement moderation eased the market from the Q1 peak.
Why did the price of Doxycycline Hydrochloride change in Q2 2026 in India?
Soft tetracycline synthesis import costs reduced the production floor. Post-spring respiratory and antimalarial prophylaxis export and domestic procurement moderation eased buying urgency. Price normalisation held the market near USD 49.3/KG after the Q1 peak.
US Doxycycline Hydrochloride prices averaged USD 54.5/KG in Q1 2026, up 4.0% from Q4 2025. Firmer synthesis intermediate costs and winter respiratory infection and antimalarial prophylaxis procurement held the market at the Q1 firming peak.
Why did the price of Doxycycline Hydrochloride change in Q1 2026 in the United States?
Firmer tetracycline synthesis intermediate costs raised the API production floor. Winter respiratory infection, antimalarial prophylaxis, and Lyme disease treatment procurement maintained buying at elevated levels. The market held at USD 54.5/KG before the Q2 correction.
Chinese prices averaged USD 37.6/KG in Q1 2026, up 3.9% from Q4 2025. Firmer domestic synthesis costs and post-Lunar New Year respiratory and antimalarial export procurement held the market at the Q1 peak.
Why did the price of Doxycycline Hydrochloride change in Q1 2026 in China?
Firmer domestic tetracycline synthesis intermediate costs raised the production floor. Post-Lunar New Year respiratory and antimalarial export procurement maintained buying at elevated levels. The market held at USD 37.6/KG before the Q2 softening.
German prices averaged USD 67.3/KG in Q1 2026, up 4.0% from Q4 2025. Firmer synthesis intermediate and energy costs and respiratory and antimalarial procurement held the European market at the Q1 peak.
Why did the price of Doxycycline Hydrochloride change in Q1 2026 in Germany?
Firmer tetracycline synthesis intermediate and energy costs raised the European production floor. Winter respiratory infection and antimalarial prophylaxis procurement maintained elevated buying. The market held at USD 67.3/KG before the Q2 softening.
Indian prices averaged USD 51.9/KG in Q1 2026, up 4.0% from Q4 2025. Firmer synthesis import costs and respiratory and antimalarial export and domestic procurement held the market at the Q1 firming peak.
Why did the price of Doxycycline Hydrochloride change in Q1 2026 in India?
Firmer tetracycline synthesis import costs raised the production floor. Respiratory infection and antimalarial prophylaxis export and domestic procurement maintained elevated buying. The market held at USD 51.9/KG before the Q2 correction.
Global Doxycycline Hydrochloride prices rose steadily through Q3 2025, Q4 2025, and Q1 2026 on firming synthesis intermediate costs and consistent antibiotic demand before correcting in Q2 2026. The average climbed from USD 42.0/KG in Q2 2025 to USD 42.84/KG in Q3, USD 44.55/KG in Q4, and USD 46.33/KG in Q1 2026, then corrected to USD 44.01/KG in Q2 2026, a net gain of about 4.8% over the window. Tetracycline synthesis intermediate cost cycles and respiratory infection and antimalarial procurement drove the rising trajectory before the Q2 correction.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 44.01 | -5.0% | ↓ Falling |
| Q1 2026 | 46.33 | +4.0% | ↑ Rising |
| Q4 2025 | 44.55 | +4.0% | ↑ Rising |
| Q3 2025 | 42.84 | +2.0% | ↑ Rising |
| Q2 2025 | 42.0 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
Doxycycline Hydrochloride prices firmed steadily through 2025 on consistent respiratory infection and antimalarial treatment demand. The global average opened near USD 41.5/KG in Q1 2025 and closed at USD 44.55/KG in Q4, a full-year gain of about 7.3%. Tetracycline synthesis intermediate cost firming and growing respiratory and antimalarial treatment procurement drove the upward trajectory.
US prices firmed from about USD 48.5/KG in Q1 2025 to USD 52.4/KG by Q4, a gain of 8.0%. Consistent respiratory infection, Lyme disease, and antimalarial prophylaxis demand supported the upward trend.
Chinese prices firmed from roughly USD 33.5/KG in Q1 2025 to USD 36.2/KG by Q4, a gain of 8.1%. Growing respiratory and antimalarial export and domestic demand drove the firming through the year.
German prices firmed from about USD 59.8/KG in Q1 2025 to USD 64.7/KG by Q4, a gain of 8.2%. Consistent respiratory infection, antimalarial prophylaxis, and Lyme disease demand and firm synthesis costs supported the market throughout the year.
Indian prices firmed from roughly USD 46.2/KG in Q1 2025 to USD 49.9/KG by Q4, a gain of 8.0%. Growing respiratory and antimalarial export and domestic demand drove consistent firming through the year.
Expert Market Research: Your Source for Real-Time Doxycycline Hydrochloride Price Intelligence
Expert Market Research tracks Doxycycline Hydrochloride prices continuously across every major producing and consuming region. The team traces causation through tetracycline synthesis intermediate economics, respiratory infection and antimalarial treatment procurement cycles, and regional API production capacity. Contact Expert Market Research today for Doxycycline Hydrochloride pricing data, bespoke market analysis, and strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Respiratory tract infection treatment including community-acquired pneumonia and atypical pneumonia takes the largest share, exploiting once-daily dosing and broad-spectrum atypical pathogen coverage. Malaria prophylaxis in chloroquine-resistant regions, Lyme disease management, chlamydial infection treatment, low-dose chronic acne management, anthrax post-exposure prophylaxis, and periodontitis treatment also consume significant volumes globally.
The Q2 2026 average was USD 51.8/KG in the United States, USD 35.7/KG in China, USD 63.9/KG in Germany, and USD 49.3/KG in India. Germany remains the highest-priced market after the Q2 correction.
The global average rose to a peak of USD 46.33/KG in Q1 2026 before correcting to USD 44.01/KG in Q2, a 5.0% quarterly decline. Sustained synthesis intermediate cost firming through Q1 and post-spring procurement moderation in Q2 drove the rise-and-correct pattern.
Tetracycline synthesis intermediate cost softening reduced the API production floor. Post-spring respiratory infection and antimalarial prophylaxis procurement moderation reduced buying urgency from the Q1 seasonal firming peak, allowing the Q2 price correction.
The global average is expected in the USD 43.50 to 48.50/KG range for H2 2026, with stabilisation as synthesis intermediate costs normalise and respiratory infection, antimalarial, and acne management treatment demand resumes at steady levels.
Germany sits highest on synthesis and energy costs, the United States and India hold a firm middle on respiratory and antimalarial demand, and China prices lowest on domestic API production capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to tetracycline synthesis intermediate costs, respiratory infection season intensity, and antimalarial prophylaxis travel demand. Oxytetracycline fermentation feedstock prices and respiratory illness surveillance data are key upstream signals.
China and India hold the largest doxycycline API production capacity. Any tetracycline synthesis intermediate cost shift ripples across markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time respiratory and antimalarial formulation contracts around synthesis cost cycles, build cover when tetracycline intermediate signals tighten, and monitor respiratory illness surveillance as the primary demand signal.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.